CytoDyn, Inc. (CYDY)
0.20
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
CytoDyn Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 27, 2020 | 547.33 |
| November 25, 2020 | 549.39 |
| November 24, 2020 | 549.39 |
| November 23, 2020 | 535.71 |
| November 20, 2020 | 524.70 |
| November 19, 2020 | 518.52 |
| November 18, 2020 | 506.18 |
| November 17, 2020 | 520.58 |
| November 16, 2020 | 543.22 |
| November 13, 2020 | 510.29 |
| November 12, 2020 | 506.18 |
| November 11, 2020 | 485.60 |
| November 10, 2020 | 415.64 |
| November 09, 2020 | 430.05 |
| November 06, 2020 | 522.64 |
| November 05, 2020 | 545.27 |
| November 04, 2020 | 555.56 |
| November 03, 2020 | 549.39 |
| November 02, 2020 | 534.99 |
| October 30, 2020 | 511.32 |
| October 29, 2020 | 491.77 |
| October 28, 2020 | 497.95 |
| October 27, 2020 | 512.35 |
| October 26, 2020 | 469.14 |
| October 23, 2020 | 506.18 |
| Date | Value |
|---|---|
| October 22, 2020 | 551.45 |
| October 21, 2020 | 555.77 |
| October 20, 2020 | 561.76 |
| October 19, 2020 | 580.25 |
| October 16, 2020 | 578.20 |
| October 15, 2020 | 613.18 |
| October 14, 2020 | 588.48 |
| October 13, 2020 | 665.65 |
| October 12, 2020 | 668.73 |
| October 09, 2020 | 672.85 |
| October 08, 2020 | 672.93 |
| October 07, 2020 | 724.29 |
| October 06, 2020 | 621.41 |
| October 05, 2020 | 636.22 |
| October 02, 2020 | 625.52 |
| October 01, 2020 | 574.08 |
| September 30, 2020 | 600.83 |
| September 29, 2020 | 640.95 |
| September 28, 2020 | 664.62 |
| September 25, 2020 | 693.42 |
| September 24, 2020 | 690.65 |
| September 23, 2020 | 705.77 |
| September 22, 2020 | 725.32 |
| September 21, 2020 | 701.63 |
| September 18, 2020 | 730.46 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.593 |
| Alnylam Pharmaceuticals, Inc. | 22.97 |
| Anika Therapeutics, Inc. | 2.023 |
| Savara, Inc. | 6.806 |
| Vericel Corp. | 5.715 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0315 |
| Price | 0.20 |
| Earnings Yield | -22.15% |
| Market Cap | 274.70M |
| PEGY Ratio | -0.0315 |